Uncategorized

Eli Lilly to pay up to $300M for cancer biotech CrossBridge Bio

Published

9 hours ago

on

Biotech entrepreneur Michael Torres is selling his antibody-drug conjugate startup CrossBridge Bio to Eli Lilly in a deal worth up to $300 million, the two companies announced Tuesday.

Torres, a PhD biologist who previously co-founded …

Related Topics:

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version